Ana C. Wing
Rio De Janeiro, RJ, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Feasibility of intra-day blood biomarker and ecological momentary assessment collection in multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: May 25, 2026
Circadian rhythmicity of symptomatic phenotypes in multiple sclerosis: the CircaMS study protocol and feasibility of biomarker collection.
Journal: BMJ open
Published: March 05, 2025
Fecal microbiota transplantation is safe and tolerable in patients with multiple sclerosis: A pilot randomized controlled trial.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: March 09, 2021
Multiple sclerosis and faecal microbiome transplantation: are you going to eat that?
Journal: Beneficial microbes
Published: December 12, 2018
Serotonin decreases the production of Th1/Th17 cytokines and elevates the frequency of regulatory CD4+ T-cell subsets in multiple sclerosis patients.
Journal: European journal of immunology
Published: January 29, 2018
Different interleukin-17-secreting Toll-like receptor+ T-cell subsets are associated with disease activity in multiple sclerosis.
Journal: Immunology
Published: September 13, 2017
Combined exercise training reduces fatigue and modulates the cytokine profile of T-cells from multiple sclerosis patients in response to neuromediators.
Journal: Journal of neuroimmunology
Published: November 24, 2015
Interleukin-17- and interleukin-22-secreting myelin-specific CD4(+) T cells resistant to corticoids are related with active brain lesions in multiple sclerosis patients.
Journal: Immunology
Published: July 23, 2015
Risk factors for convertion to clinically defined multiple sclerosis after clinically isolated syndrome in a racially mixed Brazilian cohort.
Journal: Clinical neurology and neurosurgery
Published: May 08, 2015
Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis.
Journal: Journal of neuroinflammation
Published: October 10, 2014
Endogenous interleukin-6 amplifies interleukin-17 production and corticoid-resistance in peripheral T cells from patients with multiple sclerosis.
Journal: Immunology
Published: April 23, 2014
Dopamine favors expansion of glucocorticoid-resistant IL-17-producing T cells in multiple sclerosis.
Dopamine favors expansion of glucocorticoid-resistant IL-17-producing T cells in multiple sclerosis.
Journal: Brain, behavior, and immunity
Published: March 23, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026